Anti-TPO Antibody Test: Why It’s Done and What It Means

The Anti-TPO antibody test stands as one of the most informative diagnostic tools in autoimmune thyroid disease detection. For pathologists and healthcare professionals managing thyroid disorders, precise interpretation of TPO antibody levels can distinguish between autoimmune and non-autoimmune thyroid dysfunction—a distinction that fundamentally shapes treatment approaches.

What Is the Anti-TPO Antibody Test?

The Anti-TPO Test measures the presence and levels of antithyroid peroxidase antibodies in the blood. These antibodies attack the TPO enzyme, disrupting thyroid hormone synthesis and leading to thyroid dysfunction. Thyroid peroxidase, an enzyme located within thyroid follicular cells, catalyses the oxidation of iodide and the iodination of tyrosine residues in thyroglobulin—processes essential for T3 and T4 synthesis.

When the immune system mistakenly identifies TPO as foreign, it produces antibodies that interfere with normal thyroid hormone production. High levels of these antibodies are a sign that Hashimoto's disease is causing hypothyroidism. The test serves as both a diagnostic marker and a prognostic indicator for autoimmune thyroid disease.

Primary Clinical Applications

Healthcare providers utilise the Anti-TPO antibody test across several clinical scenarios where autoimmune thyroid involvement requires confirmation or exclusion.

Hashimoto's Thyroiditis Diagnosis Almost all patients with Hashimoto's thyroiditis have high levels of TPOAb. The test proves particularly valuable when TSH elevation occurs alongside normal or borderline T4 levels.

Graves' Disease Assessment: While TSH receptor antibodies remain the primary marker for Graves' disease, TPO antibodies frequently coexist. Approximately 70% of Graves' disease patients demonstrate elevated Anti-TPO antibody test results.

Pregnancy Risk Stratification: The presence of TPO antibodies during pregnancy has been associated with increased rates of complications such as placental abruption, pregnancy-induced hypertension, preterm delivery, miscarriage, and postpartum thyroid disease, even when thyroid function is normal.

Goitre Evaluation: In patients presenting with thyroid enlargement, the test differentiates between autoimmune and non-autoimmune etiologies.

Test Preparation and Procedure

The anti-TPO antibody test requires an empty stomach, which varies among laboratories. No fasting is required unless additional tests are being conducted. Most facilities perform the test without dietary restrictions.

However, fasting may be required for concurrent lipid panels or glucose measurements.

Sample Collection Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube. Do not use oxalate, EDTA, or citrate plasma. Standard venipuncture techniques apply.

Biotin Interference The test may exhibit interference when a sample is collected from a person who is consuming a supplement with a high dose of biotin. Hence, patients should discontinue biotin supplementation 72 hours before testing.

Interpreting Test Results and Normal Range

The Anti-TPO antibody test normal range varies slightly between laboratories, but most facilities establish reference values below 35 IU/mL. Thyroid peroxidase antibody (TPOAb): Less than (<) 5.6 IU/ml represents one laboratory's reference range, while others may use slightly different cutoffs.

Result Range	Interpretation	Clinical Notes
< 35 IU/mL	Normal	Minimal or no autoimmune activity; however, it does not entirely rule out disease.
> 35 IU/mL	Elevated	Suggests active autoimmune thyroid process; may not always match symptom severity.
Borderline (near 35 IU/mL)	Requires clinical correlation	Check TSH, free T4, and symptoms; some may test positive without disease.

Factors Influencing Results

Several variables can affect Anti-TPO antibody test results beyond thyroid pathology itself.

• Interferons and lithium can elevate antibody levels independent of autoimmune thyroid disease.
• Immunosuppressive therapies may temporarily suppress antibody production, yielding false-negative results.
• Hormonal fluctuations during pregnancy can modulate antibody levels with temporary suppression followed by postpartum rebounds.
• Small numbers (3%) of people with no evidence of disease may have positive antibodies. It is more frequent in females and increases with age.
• Biotin supplementation can interfere with test accuracy and should be discontinued 72 hours before testing.

Anti-TPO antibody test cost

The cost of the Anti-TPO (Anti-Thyroid Peroxidase Antibody) test in India varies significantly based on the city, diagnostic setup, and service offerings. On average, prices range from ₹480 to ₹1500 across different regions.

In smaller cities or basic diagnostic setups, the test may be available for as low as ₹480 to ₹700. In contrast, in metro cities or premium diagnostic centres, the price may range between ₹1000 and ₹1500. Some services may also include home sample collection or faster report delivery, which could slightly affect the final cost.

Despite price differences, the test remains widely accessible and does not usually require fasting.

Clinical Decision-Making

Results require interpretation within the broader clinical context. The Anti-TPO antibody test significance extends beyond simple positive or negative determinations.

For subclinical hypothyroidism patients, positive TPO antibodies suggest a higher likelihood of progression to overt disease. In euthyroid individuals with positive antibodies, annual thyroid function monitoring becomes prudent. There is 2-4% annual risk of developing hypothyroidism.

Optimal accuracy emerges when combining TPO antibodies with thyroglobulin antibodies and TSH receptor antibodies. So the test should be used in conjunction with the antithyroglobulin test. Autoimmune thyroiditis may demonstrate a response to antigens other than thyroid microsomes.

Future Monitoring

Positive results generally remain elevated throughout the disease course. So the test is less useful for monitoring treatment compared to TSH and free T4 levels. However, dramatically changing antibody levels may signal disease progression or concurrent thyroid pathology requiring investigation.

Healthcare providers should establish monitoring based on initial antibody levels, patient symptoms, and thyroid function trends. Regular surveillance enables early intervention.

Conclusion

The Anti-TPO antibody test provides essential diagnostic information for autoimmune thyroid disease detection and risk stratification. Its integration with clinical assessment and complementary laboratory studies enables precise diagnosis and appropriate therapeutic interventions. For pathologists and healthcare professionals, mastering TPO antibody interpretation enhances diagnostic accuracy and optimises patient outcomes in thyroid disease management.

Also read - Interpreting Your Microbiology Lab Report: A Guide